Daiwa Securities Group’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-80
Closed -$2K 1469
2025
Q4
$2K Hold
80
﹤0.01% 1334
2025
Q3
$1K Hold
80
﹤0.01% 1328
2025
Q2
$2K Hold
80
﹤0.01% 1241
2025
Q1
$1K Buy
+80
New +$2.61K ﹤0.01% 1269
2022
Q4
Sell
-7
Closed 1401
2022
Q3
$0 Hold
7
﹤0.01% 1410
2022
Q2
$0 Hold
7
﹤0.01% 1441
2022
Q1
$0 Hold
7
﹤0.01% 1428
2021
Q4
$0 Hold
7
﹤0.01% 1459
2021
Q3
$0 Hold
7
﹤0.01% 1347
2021
Q2
$1K Hold
7
﹤0.01% 1224
2021
Q1
$1K Hold
7
﹤0.01% 1236
2020
Q4
$1K Sell
7
-10
-59% -$1.78K ﹤0.01% 1217
2020
Q3
$3K Buy
17
+2
+13% +$403 ﹤0.01% 1123
2020
Q2
$3K Hold
15
﹤0.01% 1146
2020
Q1
$3K Hold
15
﹤0.01% 1145
2019
Q4
$4K Sell
15
-2
-12% -$386 ﹤0.01% 1135
2019
Q3
$3K Buy
17
+4
+31% +$906 ﹤0.01% 1110
2019
Q2
$2K Hold
13
﹤0.01% 1157
2019
Q1
$3K Sell
13
-8
-38% -$1.46K ﹤0.01% 1115
2018
Q4
$4K Buy
+21
New +$6.4K ﹤0.01% 1076

Other funds holding TECX

Daiwa Securities Group's TECX Position: Q1 2026 in Review

Daiwa Securities Group sold out of Tectonic Therapeutic (TECX) in Q1 2026, closing a stake of 80 shares — an estimated $2K sold.

Daiwa Securities Group first reported a position in TECX in Q4 2018 and held it in 20 quarters. The position peaked at $4K in Q4 2019. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Daiwa Securities Group reported no remaining Tectonic Therapeutic position as of Q1 2026 after selling out during the quarter.
  • Daiwa Securities Group sold 80 Tectonic Therapeutic shares in Q1 2026, an estimated $2K.
  • Daiwa Securities Group first reported a position in Tectonic Therapeutic in Q4 2018 and held it in 20 quarters.
  • Daiwa Securities Group's Tectonic Therapeutic position peaked at $4K in Q4 2019.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Daiwa Securities Group's 13F filing for Q1 2026, filed 13 May 2026.